TBPMF
Price:
$0.0009
Market Cap:
$10.58M
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development...[Read more]
Industry
Biotechnology
IPO Date
2012-09-25
Stock Exchange
OTC
Ticker
TBPMF
According to Tetra Bio-Pharma Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.81. This represents a change of 31.54% compared to the average of 0.62 of the last 4 quarters.
The mean historical Current Ratio of Tetra Bio-Pharma Inc. over the last ten years is 9.48. The current 0.81 Current Ratio has changed 759.82% with respect to the historical average. Over the past ten years (40 quarters), TBPMF's Current Ratio was at its highest in in the February 2013 quarter at 263.56. The Current Ratio was at its lowest in in the November 2015 quarter at 0.10.
Average
9.48
Median
3.94
Minimum
0.10
Maximum
48.68
Discovering the peaks and valleys of Tetra Bio-Pharma Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 7.32%
Maximum Annual Current Ratio = 48.68
Minimum Annual Increase = -96.65%
Minimum Annual Current Ratio = 0.10
| Year | Current Ratio | Change |
|---|---|---|
| 2021 | 0.81 | 53.58% |
| 2020 | 0.53 | -61.41% |
| 2019 | 1.37 | -75.93% |
| 2018 | 5.71 | 14.34% |
| 2017 | 5.00 | -30.23% |
| 2016 | 7.16 | 7.32% |
| 2015 | 0.10 | -96.65% |
| 2014 | 2.88 | -87.20% |
| 2013 | 22.51 | -53.75% |
| 2012 | 48.68 | 197.70% |
The current Current Ratio of Tetra Bio-Pharma Inc. (TBPMF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.91
5-year avg
2.69
10-year avg
9.48
Tetra Bio-Pharma Inc.’s Current Ratio is greater than Immune Therapeutics, Inc. (0.04), less than Forward Pharma A/S (117.44), less than Bionomics Limited (2.72), less than Polydex Pharmaceuticals Limited (1.26), less than MDxHealth S.A. (1.14), greater than Tryp Therapeutics Inc. (0.24), less than HealthBeacon plc (2.54), less than Top Strike Resources Corp. (0.91), greater than Intellipharmaceutics International Inc. (0.04), greater than Carebook Technologies Inc. (0.18),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.04 | $7.78M | |
| 117.44 | $7.45M | |
| 2.72 | $8.81M | |
| 1.26 | $6.82M | |
| 1.14 | $8.65M | |
| 0.24 | $5.42M | |
| 2.54 | $8.44M | |
| 0.91 | $8.45M | |
| 0.04 | $4.96M | |
| 0.18 | $6.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tetra Bio-Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tetra Bio-Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Tetra Bio-Pharma Inc.'s Current Ratio?
How is the Current Ratio calculated for Tetra Bio-Pharma Inc. (TBPMF)?
What is the highest Current Ratio for Tetra Bio-Pharma Inc. (TBPMF)?
What is the 3-year average Current Ratio for Tetra Bio-Pharma Inc. (TBPMF)?
What is the 5-year average Current Ratio for Tetra Bio-Pharma Inc. (TBPMF)?
How does the current Current Ratio for Tetra Bio-Pharma Inc. (TBPMF) compare to its historical average?